Visceral adipose tissue and risk of COVID-19 susceptibility, hospitalization, and severity: A Mendelian randomization study

BackgroundCoronavirus Disease 2019 (COVID-19) has rapidly evolved as a global pandemic. Observational studies found that visceral adipose tissue (VAT) increased the likelihood of worse clinical outcomes in COVID-19 patients. Whereas, whether VAT is causally associated with the susceptibility, hospit...

Full description

Bibliographic Details
Main Authors: Lu Chen, Xingang Sun, Deheng Han, Jiawei Zhong, Han Zhang, Liangrong Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.1023935/full
_version_ 1797990556206366720
author Lu Chen
Xingang Sun
Deheng Han
Jiawei Zhong
Han Zhang
Liangrong Zheng
author_facet Lu Chen
Xingang Sun
Deheng Han
Jiawei Zhong
Han Zhang
Liangrong Zheng
author_sort Lu Chen
collection DOAJ
description BackgroundCoronavirus Disease 2019 (COVID-19) has rapidly evolved as a global pandemic. Observational studies found that visceral adipose tissue (VAT) increased the likelihood of worse clinical outcomes in COVID-19 patients. Whereas, whether VAT is causally associated with the susceptibility, hospitalization, or severity of COVID-19 remains unconfirmed. We aimed to investigate the causal associations between VAT and susceptibility, hospitalization, and severity of COVID-19.MethodsWe applied a two-sample Mendelian randomization (MR) study to infer causal associations between VAT and COVID-19 outcomes. Single-nucleotide polymorphisms significantly associated with VAT were derived from a large-scale genome-wide association study. The random-effects inverse-variance weighted method was used as the main MR approach, complemented by three other MR methods. Additional sensitivity analyses were also performed.ResultsGenetically predicted higher VAT mass was causally associated with higher risks of COVID-19 susceptibility [odds ratios (ORs) = 1.13; 95% confidence interval (CI), 1.09–1.17; P = 4.37 × 10−12], hospitalization (OR = 1.51; 95% CI = 1.38–1.65; P = 4.14 × 10−20), and severity (OR = 1.58; 95% CI = 1.38–1.82; P = 7.34 × 10−11).ConclusionThis study provided genetic evidence that higher VAT mass was causally associated with higher risks of susceptibility, hospitalization, and severity of COVID-19. VAT can be a useful tool for risk assessment in the general population and COVID-19 patients, as well as an important prevention target.
first_indexed 2024-04-11T08:37:18Z
format Article
id doaj.art-0a39d70a21f640ea95ba5a19f5e8e603
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-11T08:37:18Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-0a39d70a21f640ea95ba5a19f5e8e6032022-12-22T04:34:17ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-10-011010.3389/fpubh.2022.10239351023935Visceral adipose tissue and risk of COVID-19 susceptibility, hospitalization, and severity: A Mendelian randomization studyLu ChenXingang SunDeheng HanJiawei ZhongHan ZhangLiangrong ZhengBackgroundCoronavirus Disease 2019 (COVID-19) has rapidly evolved as a global pandemic. Observational studies found that visceral adipose tissue (VAT) increased the likelihood of worse clinical outcomes in COVID-19 patients. Whereas, whether VAT is causally associated with the susceptibility, hospitalization, or severity of COVID-19 remains unconfirmed. We aimed to investigate the causal associations between VAT and susceptibility, hospitalization, and severity of COVID-19.MethodsWe applied a two-sample Mendelian randomization (MR) study to infer causal associations between VAT and COVID-19 outcomes. Single-nucleotide polymorphisms significantly associated with VAT were derived from a large-scale genome-wide association study. The random-effects inverse-variance weighted method was used as the main MR approach, complemented by three other MR methods. Additional sensitivity analyses were also performed.ResultsGenetically predicted higher VAT mass was causally associated with higher risks of COVID-19 susceptibility [odds ratios (ORs) = 1.13; 95% confidence interval (CI), 1.09–1.17; P = 4.37 × 10−12], hospitalization (OR = 1.51; 95% CI = 1.38–1.65; P = 4.14 × 10−20), and severity (OR = 1.58; 95% CI = 1.38–1.82; P = 7.34 × 10−11).ConclusionThis study provided genetic evidence that higher VAT mass was causally associated with higher risks of susceptibility, hospitalization, and severity of COVID-19. VAT can be a useful tool for risk assessment in the general population and COVID-19 patients, as well as an important prevention target.https://www.frontiersin.org/articles/10.3389/fpubh.2022.1023935/fullCOVID-19visceral adipose tissueMendelian randomizationcausal associationsrisk
spellingShingle Lu Chen
Xingang Sun
Deheng Han
Jiawei Zhong
Han Zhang
Liangrong Zheng
Visceral adipose tissue and risk of COVID-19 susceptibility, hospitalization, and severity: A Mendelian randomization study
Frontiers in Public Health
COVID-19
visceral adipose tissue
Mendelian randomization
causal associations
risk
title Visceral adipose tissue and risk of COVID-19 susceptibility, hospitalization, and severity: A Mendelian randomization study
title_full Visceral adipose tissue and risk of COVID-19 susceptibility, hospitalization, and severity: A Mendelian randomization study
title_fullStr Visceral adipose tissue and risk of COVID-19 susceptibility, hospitalization, and severity: A Mendelian randomization study
title_full_unstemmed Visceral adipose tissue and risk of COVID-19 susceptibility, hospitalization, and severity: A Mendelian randomization study
title_short Visceral adipose tissue and risk of COVID-19 susceptibility, hospitalization, and severity: A Mendelian randomization study
title_sort visceral adipose tissue and risk of covid 19 susceptibility hospitalization and severity a mendelian randomization study
topic COVID-19
visceral adipose tissue
Mendelian randomization
causal associations
risk
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.1023935/full
work_keys_str_mv AT luchen visceraladiposetissueandriskofcovid19susceptibilityhospitalizationandseverityamendelianrandomizationstudy
AT xingangsun visceraladiposetissueandriskofcovid19susceptibilityhospitalizationandseverityamendelianrandomizationstudy
AT dehenghan visceraladiposetissueandriskofcovid19susceptibilityhospitalizationandseverityamendelianrandomizationstudy
AT jiaweizhong visceraladiposetissueandriskofcovid19susceptibilityhospitalizationandseverityamendelianrandomizationstudy
AT hanzhang visceraladiposetissueandriskofcovid19susceptibilityhospitalizationandseverityamendelianrandomizationstudy
AT liangrongzheng visceraladiposetissueandriskofcovid19susceptibilityhospitalizationandseverityamendelianrandomizationstudy